Skip to main content
. Author manuscript; available in PMC: 2008 Sep 22.
Published in final edited form as: Chem Biol Drug Des. 2006 Oct;68(4):183–193. doi: 10.1111/j.1747-0285.2006.00432.x

Figure 1.

Figure 1

Structure of super-potent agonist Rho-MTII. Bold line is MTII, dash line is linker, and regular line is rhodamine. In the case of the antagonist (SHU-9119), D-Nal (2′)7 is substituted for D-Phe7 in MTII.